Karachi, Ferozsons Laboratories Limited, a prominent pharmaceutical company, recently announced a revision in its recommendation regarding the increase in authorized share capital. The decision was made during the company’s board meeting held on June 20, 2023.
Previously, the Board of Directors had proposed raising the authorized share capital from Rs. 500,000,000 (Rupees Five Hundred Million) to Rs. 5,000,000,000 (Rupees Five Billion). However, after reassessment, the board revised its recommendation, suggesting a more moderate increase to Rs. 1,500,000,000 (Rupees One Billion Five Hundred Million) instead.
The post Ferozsons Laboratories Limited Reassesses Recommendation, Proposes Moderate Increase in Authorized Share Capital appeared first on Pakistan Company News.
AsiaNet-Pakistan Premier Editorial Content and Press Release Distribution Service